The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
September 26th 2025
Facilitating increased efficiency in radiation therapy planning, the new Rembra RT and Areta RT computed tomography platforms reportedly offer 4D CT capabilities and image reconstruction speeds up to 106 images per second.
ScanLab Unveils New Signal-to-Noise Ratio (SNR) Calculator for MRI
September 16th 2025Offering prospective SNR calculation derived from prescribed slices, the SNR Calculator reportedly facilitates a higher degree of accuracy with quantitative SNR values beyond that of calculators from device manufacturers.
Multicenter Study Finds Abbreviated MRI Non-Inferior to mpMRI for csPCa Detection
September 11th 2025Abbreviated biparametric MRI demonstrated nearly equivalent detection rates for clinically significant and clinically insignificant prostate cancer as multiparametric MRI, according to research involving 22 centers in 12 countries.
Study Shows Viability of Enhanced 3T MRI for Predicting Intracranial Aneurysm Instability
September 9th 2025Circumferential aneurysm wall enhancement on MRI was associated with a 3.8-fold higher risk of intracranial aneurysm instability within a four-year period, according to a study involving over 1,350 patients.
Can Photon-Counting CT Bolster Myocardial Extracellular Volume Quantification Beyond EID-CT?
September 5th 2025For myocardial extracellular volume quantification, single-phase and dual-phase photon-counting CT provided over 20 percent higher correlation with cardiac MRI in contrast to dual-phase energy-integrating detector CT, according to new research findings.
Could A Specificity Emphasis for MRI-Based T-Staging Reinvent Staging for Prostate Cancer?
August 18th 2025In a new review of MRI-based scoring systems for T-staging of prostate cancer, researchers discuss key literature findings and principles in evaluating the extent of prostate cancer (PCa) lesions, and whether a focus on specificity could enhance the staging of PCa.
Can Multimodal AI Enhance Prediction of Biochemical Recurrence After Prostatectomy?
August 8th 2025A deep learning multimodal model that incorporates MRI features offered nearly double the sensitivity for predicting post-prostatectomy biochemical recurrence of prostate cancer in comparison to the traditional CAPRA-S scoring system.
Large Medicare Study Shows Black Men Less Likely to Receive PET and MRI for Prostate Cancer Imaging
July 31st 2025An analysis of over 749,000 Medicare beneficiaries diagnosed with prostate cancer over a five-year period found that Black men were 13 percent less likely to receive PET imaging and 16 percent less likely to receive MRI in comparison to White men.